PL405801A1 - N3-aminoalkilowepochodne 5-arylidenohydantoiny i ich zastosowanie do hamowania wyrzutu leków - Google Patents

N3-aminoalkilowepochodne 5-arylidenohydantoiny i ich zastosowanie do hamowania wyrzutu leków

Info

Publication number
PL405801A1
PL405801A1 PL40580113A PL40580113A PL405801A1 PL 405801 A1 PL405801 A1 PL 405801A1 PL 40580113 A PL40580113 A PL 40580113A PL 40580113 A PL40580113 A PL 40580113A PL 405801 A1 PL405801 A1 PL 405801A1
Authority
PL
Poland
Prior art keywords
inhibiting
applications
drug efflux
aminoalkyl derivatives
arylidene
Prior art date
Application number
PL40580113A
Other languages
English (en)
Other versions
PL231082B1 (pl
Inventor
Jadwiga Handzlik
Katarzyna Kieć-Kononowicz
Anna Dela
Ewa Otrębska
Maria Kaleta
Original Assignee
Uniwersytet Jagielloński
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Uniwersytet Jagielloński filed Critical Uniwersytet Jagielloński
Priority to PL405801A priority Critical patent/PL231082B1/pl
Priority to PCT/PL2014/050069 priority patent/WO2015065212A1/en
Publication of PL405801A1 publication Critical patent/PL405801A1/pl
Publication of PL231082B1 publication Critical patent/PL231082B1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/96—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Wynalazek ujawnia nowe pochodne 3-aminoalkilowe 5-arylidenohydantoiny o wzorze I oraz ich zastosowanie do hamowania wyrzutu leków stosowanych w zapobieganiu i leczeniu chorób o podłożu bakteryjnym i/lub nowotworowym.
PL405801A 2013-10-28 2013-10-28 N3-aminoalkilowe pochodne 5-arylidenohydantoiny i ich zastosowanie do hamowania wyrzutu leków PL231082B1 (pl)

Priority Applications (2)

Application Number Priority Date Filing Date Title
PL405801A PL231082B1 (pl) 2013-10-28 2013-10-28 N3-aminoalkilowe pochodne 5-arylidenohydantoiny i ich zastosowanie do hamowania wyrzutu leków
PCT/PL2014/050069 WO2015065212A1 (en) 2013-10-28 2014-10-27 Novel n3-aminoalkyl derivatives of 5-arylidenehydantoin, pharmaceutical composition containing the above and application thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL405801A PL231082B1 (pl) 2013-10-28 2013-10-28 N3-aminoalkilowe pochodne 5-arylidenohydantoiny i ich zastosowanie do hamowania wyrzutu leków

Publications (2)

Publication Number Publication Date
PL405801A1 true PL405801A1 (pl) 2015-05-11
PL231082B1 PL231082B1 (pl) 2019-01-31

Family

ID=52469263

Family Applications (1)

Application Number Title Priority Date Filing Date
PL405801A PL231082B1 (pl) 2013-10-28 2013-10-28 N3-aminoalkilowe pochodne 5-arylidenohydantoiny i ich zastosowanie do hamowania wyrzutu leków

Country Status (2)

Country Link
PL (1) PL231082B1 (pl)
WO (1) WO2015065212A1 (pl)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL223830B1 (pl) * 2012-04-03 2016-11-30 Univ Jagiellonski Pochodne aromatycznych imidazolidynonów i ich zastosowanie

Also Published As

Publication number Publication date
WO2015065212A1 (en) 2015-05-07
PL231082B1 (pl) 2019-01-31

Similar Documents

Publication Publication Date Title
CY1124729T1 (el) Φαρμακοτεχνικες μορφες του ενζαλουταμιδιου
CY1120529T1 (el) Προφαρμακα φουμαρικων αλατων και η χρηση τους στην αγωγη ποικιλων νοσων
MX2015011984A (es) Inhibidores de bromodominio de dihidro-pirrolopiridinona.
IL254377B (en) Selective akr1c3 reductase activated prodrugs and their use for treating cancer patients
PH12016500024A1 (en) Bromodomain inhibitor
MX2015012005A (es) Inhibidores de bromodominio.
MX378273B (es) Compuestos activos hacia bromodominios.
MX375752B (es) Inhibidores de tirosina quinasa de bruton.
NZ733174A (en) Quinazoline derivatives used to treat hiv
GB201411465D0 (en) Active pharmaceutical ingredient (api) comprising cannabinoids for use in the treatment of cancer
UA118149C2 (uk) Інгібітор jak
MX2019006867A (es) Tratamiento de una enfermedad del tracto gastrointestinal con un inhibidor de integrina.
MX378726B (es) Uso de compuestos de tiazolida para la prevencion y tratamiento de enfermedades virales, cancer y enfermedades causadas por infecciones intracelulares.
GEAP202215303A (en) Chromane monobactam compounds for the treatment of bacterial infections
PL3381451T3 (pl) Kompozycja farmaceutyczna stosowana do redukcji zlokalizowanej tkanki tłuszczowej i zastosowanie kompozycji farmaceutycznej
IL271863B (en) Compounds and use thereof for the treatment of microbial infections
CR20160047A (es) Inhibidores de rorc2 y sus métodos de uso
CL2015002346A1 (es) Estra-1,3,5(10),16-tetraeno-3-carboxamidas para la inhibicion de la 17b-hidroxiesteroide deshidrogenasa (akr1 c3)
CO2019014647A2 (es) Composiciones inmunogénicas
ZA201900421B (en) Novel quinazolinone derivatives inhibiting pi3k and pharmaceutical composition containing same
CY1119532T1 (el) (s)-πιρλινδολη και τα φαρμακευτικως αποδεκτα αλατα αυτης για χρηση στην ιατρικη
MX2019010218A (es) Derivados de pirazol como inhibidores de bromodominio.
TR201905218T4 (tr) Nörodejenerati̇f hastaliklarin tedavi̇si̇ i̇çi̇n yararli vi̇tanoli̇dler.
CL2015003431A1 (es) Derivados de piridona para el tratamiento de infecciones virales y enfermedades adicionales
MX2015013755A (es) Formulacion farmaceutica para uso en el tratamiento y/o prevencion de restenosis.